Nomura Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.52M Buy
391,200
+14,600
+4% +$288K 0.02% 500
2025
Q4
$7.13M Buy
376,600
+28,400
+8% +$526K 0.02% 512
2025
Q3
$6.49M Buy
348,200
+12,100
+4% +$226K 0.02% 538
2025
Q2
$6.2M Buy
336,100
+8,600
+3% +$153K 0.02% 546
2025
Q1
$5.72M Buy
327,500
+13,400
+4% +$226K 0.02% 547
2024
Q4
$5.44M Sell
314,100
-1,500
-0.5% -$27.4K 0.02% 557
2024
Q3
$5.87M Buy
315,600
+13,600
+5% +$229K 0.02% 532
2024
Q2
$4.65M Buy
302,000
+30,800
+11% +$440K 0.02% 559
2024
Q1
$4.01M Buy
271,200
+9,100
+3% +$126K 0.01% 591
2023
Q4
$3.74M Sell
262,100
-33,000
-11% -$469K 0.02% 602
2023
Q3
$4.11M Buy
295,100
+5,600
+2% +$71.6K 0.02% 534
2023
Q2
$3.41M Buy
289,500
+9,500
+3% +$108K 0.02% 597
2023
Q1
$3.22M Sell
280,000
-10,200
-4% -$126K 0.02% 581
2022
Q4
$3.61M Buy
290,200
+14,200
+5% +$181K 0.02% 533
2022
Q3
$3.62M Buy
276,000
+9,900
+4% +$146K 0.02% 504
2022
Q2
$3.72M Buy
266,100
+64,400
+32% +$861K 0.02% 528
2022
Q1
$3M Buy
201,700
+8,700
+5% +$119K 0.02% 629
2021
Q4
$2.61M Buy
193,000
+16,800
+10% +$238K 0.01% 683
2021
Q3
$2.59M Buy
176,200
+4,900
+3% +$82.8K 0.01% 648
2021
Q2
$3.12M Buy
171,300
+4,000
+2% +$71.2K 0.02% 614
2021
Q1
$2.9M Buy
167,300
+4,600
+3% +$80.9K 0.02% 597
2020
Q4
$2.83M Buy
162,700
+2,400
+1% +$38.3K 0.02% 582
2020
Q3
$2.21M Buy
160,300
+7,400
+5% +$109K 0.02% 590
2020
Q2
$2.21M Buy
152,900
+3,200
+2% +$42.1K 0.02% 549
2020
Q1
$1.64M Buy
149,700
+23,700
+19% +$437K 0.02% 569
2019
Q4
$2.69M Buy
126,000
+5,900
+5% +$132K 0.02% 514
2019
Q3
$2.76M Buy
120,100
+6,300
+6% +$134K 0.03% 477
2019
Q2
$2.24M Buy
113,800
+1,900
+2% +$37K 0.02% 536
2019
Q1
$2.18M Sell
111,900
-700
-0.6% -$13.3K 0.02% 540
2018
Q4
$1.86M Buy
112,600
+2,500
+2% +$50.3K 0.02% 531
2018
Q3
$2.55M Buy
110,100
+2,500
+2% +$56.6K 0.02% 480
2018
Q2
$2.34M Sell
107,600
-200
-0.2% -$3.91K 0.02% 497
2018
Q1
$1.9M Buy
107,800
+5,700
+6% +$100K 0.02% 549
2017
Q4
$1.92M Buy
102,100
+10,043
+11% +$200K 0.02% 527
2017
Q3
$2.02M Buy
92,057
+49,937
+119% +$1.13M 0.03% 473
2017
Q2
$1.01M Sell
42,120
-470
-1% -$12K 0.01% 679
2017
Q1
$1.19M Buy
42,590
+800
+2% +$21K 0.02% 627
2016
Q4
$1.02M Buy
41,790
+200
+0.5% +$4.58K 0.02% 653
2016
Q3
$1.05M Buy
41,590
+600
+1% +$14.4K 0.02% 625
2016
Q2
$846K Sell
40,990
-200
-0.5% -$4.17K 0.02% 678
2016
Q1
$828K Buy
41,190
+4,760
+13% +$91.2K 0.02% 689
2015
Q4
$737K Buy
36,430
+1,300
+4% +$27.4K 0.01% 704
2015
Q3
$814K Buy
35,130
+6,620
+23% +$169K 0.02% 664
2015
Q2
$734K Buy
28,510
+3,060
+12% +$86.9K 0.01% 719
2015
Q1
$844K Buy
25,450
+4,100
+19% +$133K 0.02% 674
2014
Q4
$662K Buy
21,350
+4,600
+27% +$127K 0.01% 736
2014
Q3
$407K Buy
16,750
+2,500
+18% +$69.3K 0.01% 791
2014
Q2
$409K Buy
14,250
+2,590
+22% +$75.3K 0.01% 787
2014
Q1
$325K Hold
11,660
0.01% 811
2013
Q4
$305K Sell
11,660
-500
-4% -$12.9K 0.01% 822
2013
Q3
$280K Buy
12,160
+260
+2% +$6.41K 0.01% 810
2013
Q2
$311K Buy
+11,900
New +$343K 0.01% 790

Other funds holding SBRA